市场调查报告书
商品编码
1464824
生物样本处理市场:按类型、产品类型、最终用途、应用分类 - 2024-2030 年全球预测Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
生物样本处理市场规模预计到 2023 年为 186.2 亿美元,到 2024 年达到 198.5 亿美元,预计到 2030 年将达到 288.8 亿美元,复合年增长率为 6.47%。
生物样本处理是指以维持样本完整性并最大限度地减少污染和劣化的方式收集、储存、处理和运输生物样本,例如血液、组织和唾液。这个过程对于确保生物学研究、临床诊断和治疗性介入的可靠性至关重要。该过程包括根据生物样本的独特要求量身定制的各种协议和程序,例如温度控制、污染预防以及有关样本收集和使用的法律和道德合规性。研究与开发 (R&D) 活动的增加,特别是在基因组学、蛋白质组学和个人化医疗领域,增加了对先进样本处理解决方案的需求,以确保样本的完整性和真实性。然而,与生物样本处理相关的严格法规是主要企业面临的重大挑战。公司遵守政府法规,以在全球范围内保持永续和敏捷性。此外,自动化和冷冻保存技术的进步彻底改变了生物样本的处理。自动化系统减少了人为错误并提高了通量,而冷冻保存技术的进步则延长了样品的存活时间并支持长期研究。
主要市场统计 | |
---|---|
基准年[2023] | 186.2亿美元 |
预测年份 [2024] | 198.5亿美元 |
预测年份 [2030] | 288.8亿美元 |
复合年增长率(%) | 6.47% |
扩大采血套件和拭子的使用,以在产品运送过程中保存病毒检体
在生物样品处理中,各种产品对于准确、有效率地采集、运输和分析检体至关重要。这些重要产品包括血液采集套件,旨在安全有效地采集血液样本以进行各种诊断。拭子,如鼻拭子、鼻咽拭子和口咽拭子,是用于从特定解剖部位采集检体的专用工具,特别是在病毒病原体检测中,为采集细胞或体液进行检测提供了一种微创采集手段。此外,病毒运输介质在运输过程中保存病毒检体、确保分析前检体的完整性和活力方面发挥关键作用。每件产品均按照严格的卫生标准精密设计,以促进准确的诊断和调查,强调生物样品处理中品质和可靠性的重要性。
最终用途:在医院中更多地采用生物样本处理解决方案,以促进主动的健康管理
诊断中心是生物样本专业测试和分析的重要场所。这些设施对于准确的疾病诊断和医疗决策至关重要。居家照护是一个新兴领域,反映了向以患者为中心的医疗模式的更广泛转变。在这一领域,诸如家庭检测套组之类的创新有助于在舒适和私密的家中收集和处理生物样本,从而促进积极的健康管理。此外,医院和诊所是传统且重要的生物样本处理场所。这些机构处于患者照护的第一线,收集、分析和储存样本,以满足从常规筛检到复杂手术的广泛临床需求。
区域洞察
在美洲,生物样品处理受到严格监管,强烈要求遵守 FDA 法规和指南。最近的专利专注于提高样品处理的准确性和效率。对生物银行和个人化医疗的投资正在推动该地区对先进样本处理解决方案的需求。美国客户优先考虑可靠性和质量,并且对自动化和整合系统越来越感兴趣。同时,欧洲、中东和非洲地区拥有严格的法规环境,重点关注资料保护和病患隐私,这影响了样品处理业务。该地区对生物样本库和转化研究的投资正在增长。此外,亚太地区正在经历市场动态的动态变化,其特点是由于对生物样本库的投资增加、生物製药行业的扩张以及对研发活动的日益重视而导致显着增长。慢性病的快速增加和对个人化医疗的迫切需求是推动生物样本处理技术进步的关键驱动力。
FPNV定位矩阵
FPNV 定位矩阵对于评估生物样本处理市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生物样本处理市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.生物样本处理市场的市场规模与预测为何?
2.在生物样本处理市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.生物样本处理市场的技术趋势和法规结构是什么?
4.生物样本处理市场主要供应商的市场占有率为何?
5. 进入生物样本处理市场的合适型态和策略手段是什么?
[186 Pages Report] The Biological Sample Handling Market size was estimated at USD 18.62 billion in 2023 and expected to reach USD 19.85 billion in 2024, at a CAGR 6.47% to reach USD 28.88 billion by 2030.
Biological sample handling refers to collecting, storing, processing, and transporting biological materials, such as blood, tissue, saliva, or any other organismal specimen, in a way that preserves the integrity and minimizes contamination or degradation of the sample. This process is crucial for ensuring the reliability of biological research, clinical diagnostics, and therapeutic interventions. It encompasses a wide range of protocols and procedures tailored to the specific requirements of the biological material, including temperature control, contamination prevention, and legal and ethical compliance regarding sample collection and use. An increase in research and development (R&D) activities, especially in genomics, proteomics, and personalized medicine, drives the demand for sophisticated sample-handling solutions to ensure sample integrity and reliability. However, the strict regulations associated with biological sample handling are a significant challenge the key players face. Companies adhere to government regulations to remain sustainable and agile within the global space. Moreover, technological advancements in automation and cryopreservation have revolutionized the handling of biological samples. Automated systems reduce human error and increase throughput, while advances in cryopreservation techniques have extended the viability of samples, thereby supporting longer-term studies.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.62 billion |
Estimated Year [2024] | USD 19.85 billion |
Forecast Year [2030] | USD 28.88 billion |
CAGR (%) | 6.47% |
Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
In biological sample handling, various products are essential for the accurate and efficient collection, transport, and analysis of specimens. Among these critical products are blood collection kits designed to gather blood samples safely and effectively for various diagnostics. Swabs, including nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs, are specialized tools used for the collection of samples from specific anatomical locations, offering a minimally invasive means to acquire cells or fluids for testing, notably in the detection of viral pathogens. Additionally, viral transport media plays a pivotal role in preserving viral samples during transport, ensuring the integrity and viability of the specimens until analysis. Each product is designed with precision and adherence to stringent health standards to facilitate accurate diagnostics and research, highlighting the importance of quality and reliability in biological sample handling.
End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
Diagnostic centers are pivotal venues for specialized testing and analysis of biological samples. These facilities are essential for accurate disease diagnosis and integral to medical decision-making. Homecare represents an emerging segment reflective of a broader shift towards patient-centric healthcare models. In this domain, innovations such as at-home testing kits facilitate individuals' collection and handling of biological samples in the comfort and privacy of their homes, thereby promoting proactive health management. Moreover, hospitals & clinics are traditional and vital settings for biological sample handling. These institutions are at the forefront of patient care, with the collection, analysis, and storage of samples supporting a wide range of clinical needs, from routine check-ups to complex surgeries.
Regional Insights
In the Americas, biological sample handling is highly regulated, strongly emphasizing compliance with FDA regulations and guidelines. Recent patents have focused on improving the accuracy and efficiency of sample processing. Investments in biobanking and personalized medicine have driven the demand for advanced sample-handling solutions in this region. Customers in America prioritize reliability and quality, with a growing interest in automation and integrated systems. On the other hand, in the EMEA, the regulatory environment is stringent, with a focus on data protection and patient privacy impacting sample handling practices. Investments in biobanks and translational research are widespread in the region. Moreover, the Asia-Pacific region is witnessing a dynamic shift in the biological sample handling market, characterized by significant growth due to rising investments in biobanking, an expanding biopharmaceutical sector, and an increasing emphasis on research and development activities. The proliferation of chronic diseases and the urgent need for personalized medicine are significant drivers propelling advancements in biological sample-handling techniques.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biological Sample Handling Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Sample Handling Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biological Sample Handling Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Sample Handling Market?
3. What are the technology trends and regulatory frameworks in the Biological Sample Handling Market?
4. What is the market share of the leading vendors in the Biological Sample Handling Market?
5. Which modes and strategic moves are suitable for entering the Biological Sample Handling Market?